High levels of infiltration of CD8 + T cells, CD4 + T cells, neutrophils, B cells, M1-polarized macrophages and dendritic cells determine the pre-existing anti-tumor immune activity of patients and are associated with better prognosis and longer survival in patients receiving immunotherapy [39–41]. This evidence concerns the gene CD8A and neoplasm.